Marketdash
Back to Stock Market News

Congressional Palantir Trades Draw Scrutiny as Venezuela Connection Sends Stock Higher

MarketDash Editorial Team
2 days ago
Speculation about Palantir's role in U.S. military action in Venezuela has investors buzzing and the stock climbing. Several members of Congress who traded PLTR shares throughout 2025 could see gains, though some transactions are raising conflict of interest questions.

Sometimes the market connects dots that may or may not actually be there. Palantir Technologies (PLTR) is having one of those moments in early 2026, with its stock climbing on speculation that the data analytics company might have played a role in recent U.S. military operations in Venezuela.

Here's what makes this interesting: Several members of Congress own Palantir shares, and if this speculation proves accurate, those investments could get a nice boost. Whether that raises ethical questions is another matter entirely.

Why Palantir Is Getting Attention Now

When the U.S. government carried out military action in Venezuela, the obvious beneficiaries were oil stocks. But investors started wondering about another potential winner: Palantir, which counts the U.S. government as a major customer and has been deeply involved with military operations for years.

There's no official confirmation linking Palantir to the Venezuela operation. But that hasn't stopped social media from lighting up with theories. Mizuho analysts noted in a research report that the surge in online speculation alone made the stock worth watching, according to Barrons.

The market seems to agree. Whether or not Palantir had anything to do with Venezuela, investors are betting on the company's continued relationship with government defense operations.

Who in Congress Has Been Trading Palantir?

Congressional trading disclosures show that nine current and former representatives made Palantir transactions throughout 2025. Here's the breakdown:

Rep. Rob Bresnahan (R-Penn.)

  • April 8: Bought $1,000 to $15,000
  • Feb. 26: Sold $1,000 to $15,000
  • Feb. 25: Bought $1,000 to $15,000
  • Feb. 25: Sold $1,000 to $15,000

Rep. Gilbert Cisneros (D-Calif.)

  • Nov. 18: Bought $1,000 to $15,000
  • Nov. 7: Bought $1,000 to $15,000
  • Oct. 9: Bought $1,000 to $15,000
  • March 31: Bought $1,000 to $15,000
  • Jan. 24: Bought $1,000 to $15,000

Rep. James Comer (R-Tenn.)

  • Jan. 21: Bought $1,000 to $15,000

Rep. Cleo Fields (D-La.)

  • Oct. 10: Bought $15,000 to $50,000
  • Aug. 13: Bought $50,000 to $100,000
  • July 28: Bought $50,000 to $100,000
  • July 18: Bought $100,000 to $250,000
  • June 30: Bought $50,000 to $100,000
  • June 25: Bought $1,000 to $15,000

Former Rep. Marjorie Taylor Greene (R-Ga.)

  • July 15: Bought $1,000 to $15,000
  • Apr. 9: Bought $1,000 to $15,000
  • Apr. 8: Bought $1,000 to $15,000
  • Feb. 12: Bought $1,000 to $15,000

Rep. Julie Johnson (D-Texas)

  • June 30: Sold $1,000 to $15,000
  • April 1: Sold $1,000 to $15,000
  • Feb. 12: Bought $1,000 to $15,000
  • Jan. 15: Bought $1,000 to $15,000

Rep. Lisa McClain (R-Mich.)

  • Oct. 31: Sold $1,000 to $15,000
  • Oct. 30: Sold $1,000 to $15,000
  • Oct. 30: Bought $1,000 to $15,000
  • June 17: Bought $1,000 to $15,000

Rep. Jefferson Shreve (R-Ind.)

  • May 12: Sold $50,000 to $100,000

While Greene recently left Congress, these trades occurred during her time in office when disclosure requirements applied.

The Ethics Problem

Rep. McClain's trading history is particularly noteworthy. She chairs the House Republican Conference, making her one of the highest-ranking Republicans in Congress. But she reportedly filed several Palantir transactions late in 2025, potentially violating the STOCK Act.

In August, McClain disclosed that she had sold $50,000 to $100,000 in Palantir stock on Oct. 23, 2024, and bought $100,000 to $250,000 on Nov. 7, 2024. Both disclosures came well after the legal deadline.

The bigger question goes beyond late paperwork. Several members who traded Palantir stock serve on defense committees, which creates an obvious conflict when you're voting on matters that could affect a company in your portfolio. If Palantir was involved in the Venezuela operation or participates in other controversial government actions that split along party lines, lawmakers holding the stock face a credibility problem.

MarketDash will be monitoring whether any members of Congress bought or sold Palantir (PLTR) shares immediately following the Venezuela action, which could raise additional questions about trading on inside information.

Stock Performance

Palantir (PLTR) closed up 3.26% at $179.71 on Tuesday, adding to Monday's 3.26% gain. The back-to-back increases snapped a five-day losing streak for the stock. Over the past 52 weeks, shares have traded between $63.40 and $207.52.

Palantir was one of 2025's standout performers, gaining 134.8% for the year to rank among the top stocks in the S&P 500.

Back to Stock Market News

Congressional Palantir Trades Draw Scrutiny as Venezuela Connection Sends Stock Higher

MarketDash Editorial Team
2 days ago
Speculation about Palantir's role in U.S. military action in Venezuela has investors buzzing and the stock climbing. Several members of Congress who traded PLTR shares throughout 2025 could see gains, though some transactions are raising conflict of interest questions.

Sometimes the market connects dots that may or may not actually be there. Palantir Technologies (PLTR) is having one of those moments in early 2026, with its stock climbing on speculation that the data analytics company might have played a role in recent U.S. military operations in Venezuela.

Here's what makes this interesting: Several members of Congress own Palantir shares, and if this speculation proves accurate, those investments could get a nice boost. Whether that raises ethical questions is another matter entirely.

Why Palantir Is Getting Attention Now

When the U.S. government carried out military action in Venezuela, the obvious beneficiaries were oil stocks. But investors started wondering about another potential winner: Palantir, which counts the U.S. government as a major customer and has been deeply involved with military operations for years.

There's no official confirmation linking Palantir to the Venezuela operation. But that hasn't stopped social media from lighting up with theories. Mizuho analysts noted in a research report that the surge in online speculation alone made the stock worth watching, according to Barrons.

The market seems to agree. Whether or not Palantir had anything to do with Venezuela, investors are betting on the company's continued relationship with government defense operations.

Who in Congress Has Been Trading Palantir?

Congressional trading disclosures show that nine current and former representatives made Palantir transactions throughout 2025. Here's the breakdown:

Rep. Rob Bresnahan (R-Penn.)

  • April 8: Bought $1,000 to $15,000
  • Feb. 26: Sold $1,000 to $15,000
  • Feb. 25: Bought $1,000 to $15,000
  • Feb. 25: Sold $1,000 to $15,000

Rep. Gilbert Cisneros (D-Calif.)

  • Nov. 18: Bought $1,000 to $15,000
  • Nov. 7: Bought $1,000 to $15,000
  • Oct. 9: Bought $1,000 to $15,000
  • March 31: Bought $1,000 to $15,000
  • Jan. 24: Bought $1,000 to $15,000

Rep. James Comer (R-Tenn.)

  • Jan. 21: Bought $1,000 to $15,000

Rep. Cleo Fields (D-La.)

  • Oct. 10: Bought $15,000 to $50,000
  • Aug. 13: Bought $50,000 to $100,000
  • July 28: Bought $50,000 to $100,000
  • July 18: Bought $100,000 to $250,000
  • June 30: Bought $50,000 to $100,000
  • June 25: Bought $1,000 to $15,000

Former Rep. Marjorie Taylor Greene (R-Ga.)

  • July 15: Bought $1,000 to $15,000
  • Apr. 9: Bought $1,000 to $15,000
  • Apr. 8: Bought $1,000 to $15,000
  • Feb. 12: Bought $1,000 to $15,000

Rep. Julie Johnson (D-Texas)

  • June 30: Sold $1,000 to $15,000
  • April 1: Sold $1,000 to $15,000
  • Feb. 12: Bought $1,000 to $15,000
  • Jan. 15: Bought $1,000 to $15,000

Rep. Lisa McClain (R-Mich.)

  • Oct. 31: Sold $1,000 to $15,000
  • Oct. 30: Sold $1,000 to $15,000
  • Oct. 30: Bought $1,000 to $15,000
  • June 17: Bought $1,000 to $15,000

Rep. Jefferson Shreve (R-Ind.)

  • May 12: Sold $50,000 to $100,000

While Greene recently left Congress, these trades occurred during her time in office when disclosure requirements applied.

The Ethics Problem

Rep. McClain's trading history is particularly noteworthy. She chairs the House Republican Conference, making her one of the highest-ranking Republicans in Congress. But she reportedly filed several Palantir transactions late in 2025, potentially violating the STOCK Act.

In August, McClain disclosed that she had sold $50,000 to $100,000 in Palantir stock on Oct. 23, 2024, and bought $100,000 to $250,000 on Nov. 7, 2024. Both disclosures came well after the legal deadline.

The bigger question goes beyond late paperwork. Several members who traded Palantir stock serve on defense committees, which creates an obvious conflict when you're voting on matters that could affect a company in your portfolio. If Palantir was involved in the Venezuela operation or participates in other controversial government actions that split along party lines, lawmakers holding the stock face a credibility problem.

MarketDash will be monitoring whether any members of Congress bought or sold Palantir (PLTR) shares immediately following the Venezuela action, which could raise additional questions about trading on inside information.

Stock Performance

Palantir (PLTR) closed up 3.26% at $179.71 on Tuesday, adding to Monday's 3.26% gain. The back-to-back increases snapped a five-day losing streak for the stock. Over the past 52 weeks, shares have traded between $63.40 and $207.52.

Palantir was one of 2025's standout performers, gaining 134.8% for the year to rank among the top stocks in the S&P 500.